Scimago Lab
powered by Scopus
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 2329-0358

Get your full text copy in PDF

Polyclonal Antibodies Induction Therapy in Kidney Transplantation: a Single Center Experience

J Malaise, M De Meyer, M Mourad, J P Squifflet

Ann Transplant 2002; 7(4): 46-48

ID: 496271

In the past two decades, despite the use of more marginal donor grafts in more compromised recipients, patient and graft survival rates in kidney transplantation have significantly improved over time as surgical techniques and immunosuppressive protocols have evolved [1-5]. The trend towards increasing donor age and using donors dying from non-traumatic events results in providing grafts more prone to ischemic preservation injuries. Today, oneyear patient and graft survival in kidney transplantation reaches 95-percent and 90-percent, respectively. [1]

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree